PV Bulletin

New Restrictions on Antimicrobial Use in Veterinary Medicine

The EMA has issued guidelines for veterinarians regarding antimicrobial resistance and usage restrictions in the EU.

Primary source: View

PV Impact Brief

Urgency: HighConfidence: high

What changed

New categories of antibiotics have been established, with specific guidelines on their use in veterinary medicine to limit public health risks.

Why it matters

These guidelines are crucial for reducing antimicrobial resistance, a growing public health concern, and ultimately safeguard both human and animal health by regulating veterinary practices.

Action needed

Veterinary practitioners must now adjust their prescribing practices in accordance with the AMEG guidelines and monitor compliance with the new restrictions as outlined in the EMA's directive.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 27, 2026

Full briefing

Practical implication

Veterinary practitioners must now adjust their prescribing practices in accordance with the AMEG guidelines and monitor compliance with the new restrictions as outlined in the EMA's directive.

Veterinarians in the EU must now adhere to new guidance on the use of certain antimicrobials, categorizing them into groups with distinct usage rules to combat antimicrobial resistance effectively. The guidance includes lists of human-reserved antimicrobials that are prohibited in animal treatment and those recommended for limited use.

What changed: New categories of antibiotics have been established, with specific guidelines on their use in veterinary medicine to limit public health risks.

Why it matters: These guidelines are crucial for reducing antimicrobial resistance, a growing public health concern, and ultimately safeguard both human and animal health by regulating veterinary practices.

Practical implication: Veterinary practitioners must now adjust their prescribing practices in accordance with the AMEG guidelines and monitor compliance with the new restrictions as outlined in the EMA's directive.

View original source

  • Source: EMA - News
  • Published at source: 2026-08-27T14:30:00.000Z
  • Discovered by monitor: 2026-08-27T21:49:47.955Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward